Geron Stock (NASDAQ: GERN) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 9.48M |
Day Range | - - - |
52 Wk Range | 1.64 - 5.34 |
Market Cap | $2.60B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 11.2% |
Days to Cover | 10.24 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Geron (NASDAQ:GERN) through any online brokerage.
Other companies in Geron’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), SpringWorks Therapeutics (NASDAQ:SWTX), PTC Therapeutics (NASDAQ:PTCT) and Protagonist Therapeutics (NASDAQ:PTGX).
Geron has a consensus price target of $6.95.
The stock price for Geron (NASDAQ: GERN) is $4.31 last updated September 23, 2024 at 7:59 PM EDT.
There are no upcoming dividends for Geron.
Geron’s Q3 earnings are confirmed for Thursday, October 31, 2024.
There is no upcoming split for Geron.
Geron is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.